{"log_id": 4813859616453665688, "direction": 0, "words_result_num": 55, "words_result": [{"probability": {"variance": 0.013992, "average": 0.939168, "min": 0.57002}, "location": {"width": 513, "top": 98, "height": 33, "left": 130}, "words": "腹痛和感觉异常,口炎、舌炎、口腔念珠菌病和舌脱色也曾报道"}, {"probability": {"variance": 0.012356, "average": 0.959186, "min": 0.411555}, "location": {"width": 917, "top": 123, "height": 36, "left": 173}, "words": "曾报道散在病例发生白细胞减少症和血小板减少症。很少有报道患者服药后出现清肌酐增高,间质性肾炎和肾衰"}, {"probability": {"variance": 0.018536, "average": 0.913846, "min": 0.645085}, "location": {"width": 109, "top": 165, "height": 22, "left": 131}, "words": "胰腺炎和惊"}, {"probability": {"variance": 0.002357, "average": 0.97853, "min": 0.800488}, "location": {"width": 910, "top": 179, "height": 36, "left": 172}, "words": "假膜性喉炎在用药过程中少见,一旦发生,严重度不一,可能从轻度喉炎到威胁生命。早有病例报道低血糖,其中"}, {"probability": {"variance": 0.00084, "average": 0.978167, "min": 0.900089}, "location": {"width": 366, "top": 215, "height": 30, "left": 130}, "words": "些发生于与口服降糖成份或胰素同时服用时"}, {"probability": {"variance": 0.000634, "average": 0.986032, "min": 0.888219}, "location": {"width": 644, "top": 238, "height": 35, "left": 173}, "words": "有报道用克拉霉素治疗后牙齿变色。但牙齿变色一般经专业牙科清洁后可以消除"}, {"probability": {"variance": 0.023144, "average": 0.891432, "min": 0.631618}, "location": {"width": 100, "top": 277, "height": 23, "left": 135}, "words": "【禁总】"}, {"probability": {"variance": 0.008048, "average": 0.94704, "min": 0.695546}, "location": {"width": 262, "top": 303, "height": 23, "left": 175}, "words": "对大环内酯类抗生素过敏者禁用"}, {"probability": {"variance": 0.011259, "average": 0.954887, "min": 0.462798}, "location": {"width": 785, "top": 323, "height": 34, "left": 174}, "words": "由于克拉霉素缓释片剂量不能降至每目0.5g以下,因此它禁用于肌酐清除率低于30m/min的患者"}, {"probability": {"variance": 0.007331, "average": 0.966539, "min": 0.624245}, "location": {"width": 606, "top": 354, "height": 31, "left": 175}, "words": "克拉霉素禁止与下列药物合用:阿司眯唑、西沙必利、匹莫奇特和特非那定"}, {"probability": {"variance": 1.7e-05, "average": 0.997702, "min": 0.988648}, "location": {"width": 97, "top": 391, "height": 21, "left": 136}, "words": "【注意事项】"}, {"probability": {"variance": 0.003108, "average": 0.978359, "min": 0.743041}, "location": {"width": 684, "top": 408, "height": 35, "left": 175}, "words": "据报道,几乎所有的抗生素包括大环内酯类可能导致轻度至危及生命的假膜性大肠炎"}, {"probability": {"variance": 0.008838, "average": 0.959303, "min": 0.593844}, "location": {"width": 923, "top": 436, "height": 36, "left": 177}, "words": "克拉霉素主要经肝脏排泄,因此,对肝功能受损患者给药时应慎重。对肾功能中至重度受损患者给予克拉霉素时也应"}, {"probability": {"variance": 0, "average": 0.999967, "min": 0.999944}, "location": {"width": 40, "top": 478, "height": 20, "left": 132}, "words": "小心"}, {"probability": {"variance": 0.001741, "average": 0.980892, "min": 0.832362}, "location": {"width": 699, "top": 496, "height": 32, "left": 175}, "words": "还应注意克拉霉素与其它大环内类药物及林可霉素和克林霉素发生交叉耐药的可能性"}, {"probability": {"variance": 0.012956, "average": 0.945931, "min": 0.521787}, "location": {"width": 795, "top": 525, "height": 31, "left": 177}, "words": "β-内酰胺酶的产生应不影响克拉霉素的活性。注意:多数耐新青霉素1和Ⅱ的菌株对克拉霉素耐药"}, {"probability": {"variance": 7e-06, "average": 0.997939, "min": 0.991492}, "location": {"width": 207, "top": 560, "height": 26, "left": 139}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.016796, "average": 0.936375, "min": 0.396934}, "location": {"width": 930, "top": 579, "height": 35, "left": 173}, "words": "孕妇和哺乳期妇女服用克拉霉素的安全性尚来十分明确,孕妇使用克拉霉素应重,尤其是在妊娠头3个月。克拉"}, {"probability": {"variance": 0.012245, "average": 0.933053, "min": 0.671852}, "location": {"width": 127, "top": 618, "height": 22, "left": 135}, "words": "素可由乳汁排出"}, {"probability": {"variance": 2e-06, "average": 0.998536, "min": 0.996811}, "location": {"width": 99, "top": 647, "height": 21, "left": 140}, "words": "儿童用药】"}, {"probability": {"variance": 0.011823, "average": 0.965591, "min": 0.462738}, "location": {"width": 564, "top": 666, "height": 34, "left": 170}, "words": "12岁以上儿童,同成人。12岁以下儿童,请使用其他适宜剂型的品种"}, {"probability": {"variance": 5.7e-05, "average": 0.995488, "min": 0.978617}, "location": {"width": 99, "top": 704, "height": 22, "left": 140}, "words": "【老年用药】"}, {"probability": {"variance": 0.004938, "average": 0.975775, "min": 0.528914}, "location": {"width": 932, "top": 722, "height": 35, "left": 171}, "words": "研究者进行了一项试验,评估并比较健康老年男性和女性受试者与健康年轻成年男性受试者多次口服克拉霉素片0.5g"}, {"probability": {"variance": 0.006593, "average": 0.970157, "min": 0.513726}, "location": {"width": 950, "top": 751, "height": 37, "left": 136}, "words": "后的安全性和药物动力学情况。与年轻组相比,老年组和母体药物和14羟基代谢的循环系统血浆浓度较高,消除较慢"}, {"probability": {"variance": 0.009681, "average": 0.959282, "min": 0.53759}, "location": {"width": 899, "top": 782, "height": 35, "left": 136}, "words": "但当肾清除与肌酐清除鼻相关时,两组间无差异。由此可见,克拉霉素的体内处置与肾功能有关,而与年龄无关"}, {"probability": {"variance": 3e-06, "average": 0.99803, "min": 0.996029}, "location": {"width": 136, "top": 821, "height": 23, "left": 142}, "words": "【药物相互作用"}, {"probability": {"variance": 0.026147, "average": 0.945849, "min": 0.365376}, "location": {"width": 230, "top": 848, "height": 24, "left": 182}, "words": "与细胞色素P450的互作用"}, {"probability": {"variance": 0.00584, "average": 0.963101, "min": 0.524315}, "location": {"width": 923, "top": 868, "height": 36, "left": 182}, "words": "有数据表明,克拉霉素主要由肝细胞色素P4503A(CYP3A)同功酶代谢,这是决定许多药物相互作用的重要机制。该"}, {"probability": {"variance": 0.002071, "average": 0.980282, "min": 0.800816}, "location": {"width": 717, "top": 900, "height": 33, "left": 137}, "words": "机制下,与克拉霉素同时使用的其它药物的代谢受到抑制,从而其血清中的药物浓度升高"}, {"probability": {"variance": 0.010206, "average": 0.966029, "min": 0.361518}, "location": {"width": 925, "top": 923, "height": 39, "left": 181}, "words": "下列一些或一类药物已知或怀疑由相同的CYP3A同功酶代谢:阿唑仑、阿咪唑、卡马西平、洛他唑、西沙必"}, {"probability": {"variance": 0.011803, "average": 0.950921, "min": 0.435896}, "location": {"width": 956, "top": 953, "height": 39, "left": 137}, "words": "利、环孢菌素、丙胺、麦角生物碱、洛伐他丁、甲泼尼龙、咪达唑仑、奥美拉唑、口服抗凝剂(如:华法林)、匹莫齐特"}, {"probability": {"variance": 0.001378, "average": 0.982384, "min": 0.81835}, "location": {"width": 968, "top": 982, "height": 38, "left": 137}, "words": "奎尼丁、利发布丁、西地那非、辛伐他丁、他克莫司、特非那定、三唑仑和长春碱。通过细胞色素P450系统中其它同功"}, {"probability": {"variance": 0.001722, "average": 0.979574, "min": 0.841466}, "location": {"width": 534, "top": 1017, "height": 33, "left": 138}, "words": "酶,以相似机制发生相互作用的药物还有苯妥英、茶碱和丙戊酸盐"}, {"probability": {"variance": 0.012534, "average": 0.956685, "min": 0.510187}, "location": {"width": 881, "top": 1041, "height": 37, "left": 182}, "words": "临床研究表明,当茶碱或酰胺咪嗪与克拉霉素合用时,其循环浓度有幅度不大但有统计学意义(P≤0.05)的升高"}, {"probability": {"variance": 0.016326, "average": 0.916133, "min": 0.457062}, "location": {"width": 751, "top": 1070, "height": 39, "left": 182}, "words": "克拉得素与HMG-CoA还原酶抑制剂(如洛伐他丁和辛伐他丁)合用,极少有横纹肌溶解的报道"}, {"probability": {"variance": 0.009258, "average": 0.97382, "min": 0.445648}, "location": {"width": 927, "top": 1097, "height": 40, "left": 182}, "words": "西沙必利与克拉霉素合用会升高病人西沙必利血药浓度,导致QT间期延长,心律失常如室性心动过速、室颤和峰"}, {"probability": {"variance": 0.000929, "average": 0.985904, "min": 0.842199}, "location": {"width": 514, "top": 1134, "height": 31, "left": 140}, "words": "值扭转。克拉霉素与匹莫齐特合用也会有此作用(参见【禁忌】)"}, {"probability": {"variance": 0, "average": 0.748165, "min": 0.748165}, "location": {"width": 46, "top": 1128, "height": 27, "left": 731}, "words": "中"}, {"probability": {"variance": 0.021594, "average": 0.940448, "min": 0.399418}, "location": {"width": 924, "top": 1155, "height": 40, "left": 186}, "words": "大环内酯类药物能改变特非那定的代谢面升高其血药浓度,时伴心律失常如Q铜期延长c室性心动过速、颜和"}, {"probability": {"variance": 0.016174, "average": 0.946301, "min": 0.450113}, "location": {"width": 967, "top": 1185, "height": 39, "left": 143}, "words": "峰值扭转(参见【禁忌】)。对14名健康受试者的研究发现,克拉霉素与特非那定合用会引起特非那定的酸性代谢物血药浓"}, {"probability": {"variance": 0.011704, "average": 0.951117, "min": 0.526457}, "location": {"width": 925, "top": 1215, "height": 38, "left": 141}, "words": "度升高2~3倍,导致Q-T间期延长,但无任何临床症状。阿司咪唑与代它大环内酯同时给药时也治观察到相似反应"}, {"probability": {"variance": 0.00325, "average": 0.97242, "min": 0.683411}, "location": {"width": 924, "top": 1244, "height": 37, "left": 185}, "words": "有上市后报道,当克拉霉素和奎尼丁或丙毗胺合用时有转峰值现象发生。使用克拉霉素治疗时应监测这些药物的血"}, {"probability": {"variance": 0.000362, "average": 0.985797, "min": 0.958908}, "location": {"width": 55, "top": 1287, "height": 22, "left": 143}, "words": "药浓度"}, {"probability": {"variance": 0.000179, "average": 0.993811, "min": 0.954932}, "location": {"width": 182, "top": 1314, "height": 24, "left": 144}, "words": "与其它药物的相互作用"}, {"probability": {"variance": 0.012849, "average": 0.961058, "min": 0.36849}, "location": {"width": 645, "top": 1335, "height": 34, "left": 186}, "words": "克拉霉素与地高辛合用会引起地高辛血药浓度升,散应考虑进行血药浓度监测"}, {"probability": {"variance": 3e-06, "average": 0.998435, "min": 0.993306}, "location": {"width": 259, "top": 1371, "height": 29, "left": 143}, "words": "与抗逆转录病毒药物的相互作用"}, {"probability": {"variance": 0.013195, "average": 0.93754, "min": 0.570148}, "location": {"width": 922, "top": 1390, "height": 39, "left": 186}, "words": "HIV感染的成年人同时口服克拉霉素片与叠氮胸苷( (zidovudine)会引起叠氮胸苷稳态血药浓度下降。因为克拉霉素似"}, {"probability": {"variance": 0.006232, "average": 0.962125, "min": 0.599659}, "location": {"width": 968, "top": 1421, "height": 39, "left": 144}, "words": "乎会干扰同时给药的口服叠氮胸苷的吸收。至今,HIV感染的儿科病人未出现上述相互影响。尚未进行相似的克拉霉素缓"}, {"probability": {"variance": 0.000685, "average": 0.981794, "min": 0.913328}, "location": {"width": 255, "top": 1462, "height": 26, "left": 145}, "words": "释片与叠氮胸苷的相互作用研究"}, {"probability": {"variance": 0.007052, "average": 0.955133, "min": 0.555735}, "location": {"width": 918, "top": 1479, "height": 39, "left": 188}, "words": "药动学研究表明,利托那书(0.2g,每8h一次)和克拉霉素(0.5g,每12h一次)合用会导致克拉素代谢物的明显抑制"}, {"probability": {"variance": 0.009983, "average": 0.941557, "min": 0.55822}, "location": {"width": 966, "top": 1510, "height": 37, "left": 146}, "words": "克拉霉素的 Cmar Cot和AUC分别增加31%,182%和77%,14-(R)羟基克拉霉索的形成受到明显抑制。由于克拉霉素治疗"}, {"probability": {"variance": 0.000799, "average": 0.984087, "min": 0.883683}, "location": {"width": 883, "top": 1539, "height": 37, "left": 145}, "words": "窗较大,当病人肾功能正常时,无需减少剂量,但对肾功能损伤的病人,应按以下方法进行剂量调整:Clc为30"}, {"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 17, "top": 1543, "height": 18, "left": 1092}, "words": " )In"}, {"probability": {"variance": 0.021476, "average": 0.927302, "min": 0.415216}, "location": {"width": 923, "top": 1567, "height": 38, "left": 147}, "words": "的思者,克拉霉剂量减少50%,即最大剂量为每天服用片克拉霉素缓释片。肾功能严重受损患者(Clcx小于30m"}, {"probability": {"variance": 0.011197, "average": 0.953604, "min": 0.496026}, "location": {"width": 965, "top": 1597, "height": 37, "left": 149}, "words": "不宜使用克拉霉素缓释片,因为这种产品无法减少剂量,这一人群可使用克拉霉素片。克拉霉素每天剂量大于lg时,不"}], "language": 3}